$CYDY
CytoDyn Inc.

2015 Q2 Form 10-K Financial Statement

#000119312515250418 Filed on July 10, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2 2014
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.530M $950.0K $3.780M
YoY Change 61.05% -28.57% -47.13%
% of Gross Profit
Research & Development $8.740M $1.590M $3.981M
YoY Change 449.69% 329.73% 542.34%
% of Gross Profit
Depreciation & Amortization $90.00K $90.00K $350.0K
YoY Change 0.0% -59.09% 59.09%
% of Gross Profit
Operating Expenses $10.36M $2.640M $8.113M
YoY Change 292.42% 38.22% 1.49%
Operating Profit -$8.113M
YoY Change 1.49%
Interest Expense -$3.330M -$430.0K $4.510M
YoY Change 674.42% -54.26% 131.44%
% of Operating Profit
Other Income/Expense, Net -$320.0K $70.00K $180.0K
YoY Change -557.14% -81.08% -51.35%
Pretax Income -$14.00M -$3.000M -$12.43M
YoY Change 366.67% 20.48% 29.92%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.00M -$3.000M -$12.43M
YoY Change 366.67% 20.48% 29.92%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$223.8K -$53.34K -$265.0K
COMMON SHARES
Basic Shares Outstanding 70.14M shares 55.75M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.050M $4.890M $4.890M
YoY Change -78.53% 715.0% 715.0%
Cash & Equivalents $1.050M $4.886M
Short-Term Investments
Other Short-Term Assets $990.0K $560.0K $560.0K
YoY Change 76.79% 133.33% 133.33%
Inventory
Prepaid Expenses $253.8K $488.8K
Receivables
Other Receivables
Total Short-Term Assets $2.038M $5.443M $5.440M
YoY Change -62.56% 547.65% 547.62%
LONG-TERM ASSETS
Property, Plant & Equipment $24.21K $16.80K $20.00K
YoY Change 44.15%
Goodwill
YoY Change
Intangibles $2.617M $2.967M
YoY Change -11.8% -10.55%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.641M $2.984M $2.990M
YoY Change -11.48% -10.04% -9.94%
TOTAL ASSETS
Total Short-Term Assets $2.038M $5.443M $5.440M
Total Long-Term Assets $2.641M $2.984M $2.990M
Total Assets $4.679M $8.427M $8.430M
YoY Change -44.47% 102.69% 102.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.016M $1.287M $1.290M
YoY Change 289.85% 15.79% 16.22%
Accrued Expenses $1.570M $65.00K $500.0K
YoY Change 2315.38% -79.81% -32.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due -$43.47K
YoY Change
Total Short-Term Liabilities $10.73M $2.166M $2.170M
YoY Change 395.08% -32.9% -32.82%
LONG-TERM LIABILITIES
Long-Term Debt $2.640M $2.339M $2.340M
YoY Change 12.88% 102.83% 103.48%
Other Long-Term Liabilities $2.010M
YoY Change
Total Long-Term Liabilities $4.650M $2.339M $2.340M
YoY Change 98.83% 102.83% 103.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.73M $2.166M $2.170M
Total Long-Term Liabilities $4.650M $2.339M $2.340M
Total Liabilities $15.37M $4.505M $4.510M
YoY Change 241.21% 2.82% 2.97%
SHAREHOLDERS EQUITY
Retained Earnings -$71.52M -$46.43M
YoY Change 54.03% 36.56%
Common Stock $63.64K $30.37M
YoY Change -99.79% 88.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.69M $3.922M $3.920M
YoY Change
Total Liabilities & Shareholders Equity $4.679M $8.427M $8.430M
YoY Change -44.47% 102.69% 102.64%

Cashflow Statement

Concept 2015 Q2 2014 Q2 2014
OPERATING ACTIVITIES
Net Income -$14.00M -$3.000M -$12.43M
YoY Change 366.67% 20.48% 29.92%
Depreciation, Depletion And Amortization $90.00K $90.00K $350.0K
YoY Change 0.0% -59.09% 59.09%
Cash From Operating Activities -$4.250M -$1.750M -$7.387M
YoY Change 142.86% 76.77% 117.72%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K $19.22K
YoY Change -100.0% 513.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.00K -$19.22K
YoY Change -100.0% -99.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.64M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.630M -750.0K 11.69M
YoY Change -584.0% -163.56% 62.03%
NET CHANGE
Cash From Operating Activities -4.250M -1.750M -7.387M
Cash From Investing Activities 0.000 -10.00K -19.22K
Cash From Financing Activities 3.630M -750.0K 11.69M
Net Change In Cash -620.0K -2.510M -7.406M
YoY Change -75.3% -1421.05% -2423.94%
FREE CASH FLOW
Cash From Operating Activities -$4.250M -$1.750M -$7.387M
Capital Expenditures $0.00 -$10.00K $19.22K
Free Cash Flow -$4.250M -$1.740M -$7.406M
YoY Change 144.25% 75.76% 118.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q3 us-gaap Forward Contract Indexed To Issuers Equity Indexed Shares
ForwardContractIndexedToIssuersEquityIndexedShares
2000000 shares
CY2014Q3 us-gaap Convertible Debt
ConvertibleDebt
2000000
CY2014Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
767038
CY2014Q4 dei Entity Public Float
EntityPublicFloat
64183157
CY2015Q1 us-gaap Forward Contract Indexed To Issuers Equity Indexed Shares
ForwardContractIndexedToIssuersEquityIndexedShares
1500000 shares
CY2015Q1 us-gaap Convertible Debt
ConvertibleDebt
1500000
CY2015Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
403266
CY2013Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.75
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.75
CY2013Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.07 pure
CY2013Q2 us-gaap Convertible Debt
ConvertibleDebt
3981050
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-223916
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
603681
CY2013Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
18146838 shares
CY2013Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
1.65
CY2013Q2 cydy Convertible Notes Face Amount
ConvertibleNotesFaceAmount
6588250
CY2013Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
140321
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.65
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55753311 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55753311 shares
CY2014Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2166355
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20100434
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2338684
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
159300
CY2014Q2 us-gaap Liabilities
Liabilities
4505039
CY2014Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
0
CY2014Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2338684
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
568750
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
30367779
CY2014Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1500000
CY2014Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7221250
CY2014Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
663700
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
2338684
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-12363200
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
266251
CY2014Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
378000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46434232
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
3922232
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8427271
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1286715
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2967239
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16797
CY2014Q2 us-gaap Assets Current
AssetsCurrent
5443235
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2893300
CY2014Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
68292
CY2014Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2014Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
176200
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
159300
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
488821
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2931250
CY2014Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4589000
CY2014Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4886122
CY2014Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1932566
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
0
CY2014Q2 us-gaap Assets
Assets
8427271
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9957400
CY2014Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
30806361 shares
CY2014Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
1.13
CY2014Q2 cydy Common And Preferred Stock Subject To Rescission
CommonAndPreferredStockSubjectToRescission
378000
CY2014Q2 cydy Convertible Notes Face Amount
ConvertibleNotesFaceAmount
1200000
CY2014Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
177042
CY2014Q2 cydy Accrued Salaries And Interest Payable Current
AccruedSalariesAndInterestPayableCurrent
501640
CY2014Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63644348 shares
CY2015Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
5.00
CY2015Q2 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
0.15
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2015Q2 us-gaap Forward Contract Indexed To Issuers Equity Indexed Shares
ForwardContractIndexedToIssuersEquityIndexedShares
5185185 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63644348 shares
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10725252
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24762990
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
219100
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
-43471
CY2015Q2 us-gaap Liabilities
Liabilities
15371777
CY2015Q2 us-gaap Convertible Debt
ConvertibleDebt
4862257
CY2015Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
0
CY2015Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2220143
CY2015Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2008907
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
918750
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
35819240
CY2015Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
2008907
CY2015Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
50000
CY2015Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2015Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4271250
CY2015Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
902700
CY2015Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2008907
CY2015Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1634458
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
43471
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19240100
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
247556
CY2015Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71522302
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-10692516
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4679261
CY2015Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2008907
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5016261
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2617239
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24213
CY2015Q2 us-gaap Assets Current
AssetsCurrent
2037809
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3073500
CY2015Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
350000
CY2015Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2015Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
733916
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
49581217
CY2015Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
211700
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
350000
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
219100
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
253833
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2581250
CY2015Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1164000
CY2015Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1050060
CY2015Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6529
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
0
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
350000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
350000
CY2015Q2 us-gaap Assets
Assets
4679261
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16857600
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
350000
CY2015Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
5334919
CY2015Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
31008915 shares
CY2015Q2 cydy Increase Decrease In Conversion Price
IncreaseDecreaseInConversionPrice
0.675
CY2015Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.88
CY2015Q2 cydy Common Stock Weighted Average Price
CommonStockWeightedAveragePrice
0.75
CY2015Q2 cydy Accrued Milestone Payments
AccruedMilestonePayments
2500000
CY2015Q2 cydy Amortization Of Debt Discount
AmortizationOfDebtDiscount
219000
CY2015Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.89
CY2015Q2 cydy Working Capital Deficit
WorkingCapitalDeficit
8687443
CY2015Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
29898494 shares
CY2015Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
5538335
CY2015Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
930000
CY2015Q2 cydy Accrued Salaries And Interest Payable Current
AccruedSalariesAndInterestPayableCurrent
644533
CY2015Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70142332 shares
CY2012Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0182 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.36 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0148 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.19 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015Q2 cydy Sale Of Common Stock Price Per Share
SaleOfCommonStockPricePerShare
0.75
CY2015Q2 cydy Fair Value Assumptions Adjusted Conversion Price
FairValueAssumptionsAdjustedConversionPrice
0.675
CY2013 us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2013-11-30
CY2013 us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2016-03-06
CY2013 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life In Years
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeInYears
P1Y10M10D
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7873 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004 pure
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30806361 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9292 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.248 pure
CY2014 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2087717 shares
CY2014 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.096 pure
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7386943
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0052 pure
CY2014 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2013-10-01
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46900643 shares
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.000 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0185 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2450000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19220
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
120000
CY2014 us-gaap Stock Issued1
StockIssued1
58518
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12431413
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
928413
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-8112728
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
193160
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
500000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
7767
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1200000
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2084063
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2459000
CY2014 us-gaap Interest Paid
InterestPaid
311991
CY2014 us-gaap Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
183944
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-12431413
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
500000
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
348972
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0
CY2014 us-gaap Interest Expense
InterestExpense
4510396
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13642667
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
352429
CY2014 us-gaap Operating Expenses
OperatingExpenses
8112728
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3807320
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11688604
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Legal Fees
LegalFees
672153
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3807000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3106678
CY2014 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
-2084063
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176064
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1200000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3807320
CY2014 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
193160
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4282441
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
583076
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
50000
CY2014 us-gaap Debt Issuance Costs
DebtIssuanceCosts
120000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
928413
CY2014 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
120000
CY2014 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19220
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3981468
CY2014 cydy Rescission Expirations And Exclusions
RescissionExpirationsAndExclusions
158500
CY2014 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
1
CY2014 cydy Original Issue Discount And Intrinsic Value Of Beneficial Conversion Feature Related To Debt
OriginalIssueDiscountAndIntrinsicValueOfBeneficialConversionFeatureRelatedToDebt
1200000
CY2014 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.49
CY2014 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.74
CY2014 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
5704721 shares
CY2014 cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
28638
CY2014 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
13642667
CY2014 cydy Amortization Of Deferred Offering Cost Related To Rescission Liability
AmortizationOfDeferredOfferingCostRelatedToRescissionLiability
28636
CY2014 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
50000 shares
CY2014 cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
158500
CY2014 cydy Debt Conversion Converted Instrument Interest Amount
DebtConversionConvertedInstrumentInterestAmount
6351
CY2014 cydy Issuance Of Common Stock In Private Stock Offering Unit
IssuanceOfCommonStockInPrivateStockOfferingUnit
1.3
CY2014 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
50000
CY2014 cydy Accounts Payable Extinguished Through Settlements
AccountsPayableExtinguishedThroughSettlements
183944
CY2014 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life In Years
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeInYears
P3Y3M15D
CY2014 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
18414244 shares
CY2014 cydy Conversion Instruments Exercised
ConversionInstrumentsExercised
250000
CY2015 dei Document Type
DocumentType
10-K
CY2015 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
10559919 shares
CY2015 dei Trading Symbol
TradingSymbol
CYDY
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0012 pure
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-05-31
CY2015 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2015 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total shareholders&#x2019; (deficit) equity or net loss.</p> </div>
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7436 pure
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000 pure
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31008915 shares
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8116 pure
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.322 pure
CY2015 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.43
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.006 pure
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P6M
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12016858
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0073 pure
CY2015 dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC
CY2015 us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
0.25
CY2015 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
285118 shares
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58375637 shares
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.000 pure
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
631302
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0110 pure
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.8068 pure
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4221250
CY2015 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-838643
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18585
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
423104
CY2015 us-gaap Stock Issued1
StockIssued1
138373
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25088070
CY2015 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
555626
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-19596526
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
970367
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
2199
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-583
CY2015 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
1170264
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4221250
CY2015 us-gaap Interest Paid
InterestPaid
203864
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
838643
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-25088070
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
3142
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
498928
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0
CY2015 us-gaap Interest Expense
InterestExpense
4655100
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
360582
CY2015 us-gaap Operating Expenses
OperatingExpenses
19596526
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2145010
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8199381
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Legal Fees
LegalFees
796671
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2145000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3282908
CY2015 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
523614
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7440554
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7481050
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2145010
CY2015 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1526254
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3836062
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
356624
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1141435
CY2015 us-gaap Debt Issuance Costs
DebtIssuanceCosts
708000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
631302
CY2015 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
103598
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18585
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15156365
CY2015 cydy Rescission Expirations And Exclusions
RescissionExpirationsAndExclusions
378000
CY2015 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.76
CY2015 cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
CY2015 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.93
CY2015 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
7020510 shares
CY2015 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Life In Years
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualLifeInYears
P2Y10M28D
CY2015 cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
68292
CY2015 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
CY2015 cydy Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P5Y
CY2015 cydy Amortization Of Deferred Offering Cost Related To Rescission Liability
AmortizationOfDeferredOfferingCostRelatedToRescissionLiability
68292
CY2015 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.55
CY2015 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
2038974 shares
CY2015 cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
378000
CY2015 cydy Class Of Warrant Or Right Granted Intrinsic Value
ClassOfWarrantOrRightGrantedIntrinsicValue
-2505261
CY2015 cydy Constructive Dividend To Preferred Stock Holders
ConstructiveDividendToPreferredStockHolders
6000000
CY2015 cydy License Fee
LicenseFee
300000
CY2015 cydy Number Of Patent License Agreement
NumberOfPatentLicenseAgreement
3 Patent
CY2015 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life In Years
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeInYears
P2Y11M9D
CY2015 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
9262038 shares
CY2015 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
-0.012 pure
CY2013Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2013Q2 cydy Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P5Y
CY2015Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-838643
CY2015Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
523614
CY2015Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4000000
CY2015Q2 cydy Weighted Average Price Common Stock Percentage
WeightedAveragePriceCommonStockPercentage
0.90 pure

Files In Submission

Name View Source Status
0001193125-15-250418-index-headers.html Edgar Link pending
0001193125-15-250418-index.html Edgar Link pending
0001193125-15-250418.txt Edgar Link pending
0001193125-15-250418-xbrl.zip Edgar Link pending
cydy-20150531.xml Edgar Link completed
cydy-20150531.xsd Edgar Link pending
cydy-20150531_cal.xml Edgar Link unprocessable
cydy-20150531_def.xml Edgar Link unprocessable
cydy-20150531_lab.xml Edgar Link unprocessable
cydy-20150531_pre.xml Edgar Link unprocessable
d944111d10k.htm Edgar Link pending
d944111dex1025.htm Edgar Link pending
d944111dex231.htm Edgar Link pending
d944111dex24.htm Edgar Link pending
d944111dex311.htm Edgar Link pending
d944111dex312.htm Edgar Link pending
d944111dex32.htm Edgar Link pending
d944111dex410.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending